Expanding into the Swiss medical device market requires more than EU MDR or EU IVDR compliance. Manufacturers must also meet Switzerland’s unique regulatory requirements, from CH-REP appointment and CHRN registration to labeling and post-market surveillance.
Registration is the first step toward Swiss market access. This guide walks through the registration, compliance, labeling and post-market surveillance requirements manufacturers must clear to enter the Swiss medical device market.
Regulatory Authorities for Medical Devices in Switzerland
Swissmedic regulates medical devices in Switzerland under the Therapeutic Products Act. Two ordinances implement that Act:
- MedDO for general medical devices
- IvDO for in vitro diagnostics.
Manufacturers can find these documents on Fedlex, its official federal law platform. Though they mirror the framework of EU MDR and EU IVDR, they incorporate Swiss-specific mandates.
The Federal Office of Public Health (FOPH) sets broad health policy. Swissmedic handles daily regulation and registration. Manufacturers must remember this distinction before contacting them. Manufacturers often contact the FOPH and face redirection.
Switzerland Medical Device Classification
MedDO classification follows the same risk-based logic as EU MDR. General medical devices are classified as Class I, IIa, IIb or III. Class I is the low risk end, through IIa and IIb to Class III at the high risk end.
IVD devices fall into Class A, B, C, or D under the IvDO.
For general medical devices, Class I includes additional subcategories. These comprise Class Is (sterile), Class Im (measuring) and Class Ir (reusable surgical instruments).
Switzerland’s classification framework closely tracks the EU system but Swissmedic retains independent authority to interpret classification requirements. This matters most for software as a medical device (SaMD) and combination products. Swissmedic’s guidance for these categories references MDCG 2019-11, covering software qualification and classification.
Authorized Representative (CH-REP) Requirements in Switzerland
Manufacturers without a registered place of business in Switzerland must appoint a Swiss Authorized Representative (CH-REP) before placing a medical device on the Swiss market.
The appointment remains mandatory even for manufacturers based in the EU. A CH-REP and an EU Authorized Representative perform separate regulatory responsibilities and one cannot replace the other.
Key responsibilities of the CH-REP include:
- Verifying that the manufacturer has properly prepared the Declaration of Conformity and technical documentation.
- Ensuring the manufacturer complies with applicable registration obligations.
- Retaining the required regulatory documentation for 10 years, or 15 years for implantable devices.
- Serving as the primary point of contact for Swissmedic.
- Sharing joint legal liability with the manufacturer for defective medical devices.
The device packaging must bear the CH-REP’s name and address together with the “CH-REP” symbol.
Due to the Customs Treaty governing relations between Switzerland and Liechtenstein, manufacturers with a registered place of business in Liechtenstein are not required to designate a CH-REP. It’s a narrow exception and one manufacturers often overlook when mapping out their EU-plus-Switzerland entity structure.
Medical Device Regulatory Guidelines in Switzerland
Beyond Therapeutic Products Act, MedDO and IvDO, Swissmedic issues guidance documents and information sheets clarifying regulatory expectations.
These publications address several key areas, including:
- Combination products
- Software qualification and classification
- Importer obligations
- Economic operator responsibilities
- Post-market surveillance and vigilance
Even though these documents are not legally binding, they still reflect Swissmedic’s regulatory expectations and factor into compliance assessments. Manufacturers should incorporate them into their regulatory strategy.
International Standards Recognized by Swissmedic:
- ISO 13485:2016 for quality management systems
- ISO 14971:2019 for risk management
- ISO 14155 covering clinical investigations
- ISO 10993 series on biological evaluation
- IEC 62304 for software lifecycle processes
Swissmedic treats these as key technical references for conformity assessment, matching the EU MDR approach. Manufacturers already certified to these standards for EU market access typically don’t need to start from scratch for Switzerland.
Medical Device Registration Process in Switzerland
Medical device registration in Switzerland begins with the applicable conformity assessment, followed by compliance with the country’s regulatory requirements. The typical step by step registration process is outlined below.
Step 1: Classify your device
Begin the registration process by determining the device’s risk classification under the MedDO or IvDO. The classification establishes the applicable conformity assessment route, regulatory documentation and notified body requirements.
Step 2: Complete the conformity assessment
Confirm that the device has successfully completed the applicable conformity assessment. Manufacturers should prepare the EU Declaration of Conformity, maintain complete technical documentation and obtain any required notified body certification.
If the device requires notified body assessment, ensure the CE certificate has been issued by a notified body recognized under Switzerland’s MedDO or IvDO.
Step 3: Sign the CH-REP mandate
Appoint a Swiss Authorized Representative through a signed written agreement. This needs to be in place before any device is placed on the Swiss market and an existing EU Authorized Representative does not count as a substitute.
Step 4: Apply for and receive your CHRN
Submit the registration application to Swissmedic. Processing takes up to 30 days (per Swissmedic’s published guidance), though it can move faster if their application volume is light. Manufacturers will receive your Swiss Single Registration Number (CHRN) once Swissmedic verifies the information.
Step 5: Confirm importer compliance
Verify that the Swiss importer complies with the requirements of Article 53 of the MedDO before the device enters the Swiss market. Importers must obtain their own Swiss Single Registration Number (CHRN), while distributors are not required to register for a CHRN.
Step 6: Update labeling and IFUs
Manufacturers should add the CH-REP symbol, name and address to packaging. Confirm instructions for use are available in German, French and Italian, with exemptions only for professional-use-only devices.
Step 7: Complete Swiss device notification (where applicable)
Submit the required device notification through the appropriate Swiss registration system. Until 1 July 2026, notifications are submitted to Swissmedic under the interim process. Thereafter, applicable device and IVD notifications must be completed through Swissdamed.
Manufacturers should verify the notification requirements for their device category, as Class I devices, custom-made devices and certain other devices may follow different notification obligations.
Step 8: Maintain post-market compliance
Establish post-market surveillance, report serious incidents to Swissmedic through the CH-REP where applicable, and maintain PMS documentation, PSURs, and vigilance records in accordance with the MedDO or IvDO.
Required Documents for Medical Device Registration in Switzerland
Manufacturers should prepare the following documentation before placing a medical device on the Swiss market:
- CH-REP mandate agreement
- Declaration of Conformity (DoC) prepared in accordance with Article 29 of the MedDO or Article 25 of the IvDO, as applicable
- Conformity assessment certificate issued by the relevant EU or EEA notified body (where required)
- Technical documentation supporting the conformity assessment
- Evidence of CHRN (Swiss Single Registration Number) application or assignment
- Importer details, where applicable
- Software documentation aligned with MDCG 2019-11 for software as a medical device (SaMD), where applicable
Swissmedic has clarified that conformity assessment certificates don’t need to reference the CHRN, the CH-REP, or the MedDO by name. EU-issued conformity certificates work as it is, without added Swiss-specific information.
QMS Requirements for Medical Devices in Switzerland
Swiss regulations require a QMS proportionate to a device’s nature and risk class. That QMS must align with ISO 13485:2016.
The QMS should address key processes such as
- Design and development controls
- Supplier qualification and purchasing controls
- Manufacturing and production processes
- Risk management
- Complaint handling procedures
- Corrective and preventive actions (CAPA)
- Post-market surveillance (PMS)
- Technical documentation management
Switzerland also requires hospitals using medical devices to maintain a QMS, designate a vigilance contact person and keep vigilance records for 15 years. None of this appears in the EU framework. It’s Swiss-specific.
Medical Device Labeling & IFU Requirements in Switzerland
Labels must comply with MedDO or IvDO requirements. At a minimum, the label should include:
- Manufacturer’s name and registered address
- Device identification: model, catalog, batch, or serial number
- CE marking, plus notified body ID number if one applies
- CH-REP name and address, when required
- Importer details, if applicable
- Safety information and regulatory symbols, as required
Manufacturers must also provide the label and instructions for use (IFU) in German, French, and Italian, Switzerland’s three official languages. Exemptions apply to certain professional-use-only devices.
Manufacturers selling into both the EU and Switzerland should watch the language gap closely. EU multilingual labeling often covers English, French and German. But Switzerland generally requires Italian too. This is the compliance gap that usually catches manufacturers off guard.
Registration Timelines for Medical Devices in Switzerland
No fixed registration timeline applies to all medical devices in Switzerland. Swissmedic determines processing times based on the device classification, the completeness of the application and its administrative capacity.
For administrative processes, Swissmedic generally issues a CHRN within 30 days of receiving a complete application. The authority also processes complete device notifications submitted through the current interim notification system in approximately one month, although incomplete or deficient submissions may extend the review period.
Manufacturers should expect to complete the CH-REP appointment and CHRN registration before the overall market access process is finalized. Higher-risk devices generally require additional time because they are subject to more rigorous conformity assessment and technical documentation requirements.
As of 1 July 2026, Switzerland will replace the interim notification process with mandatory submissions through Swissdamed for medical devices and IVDs. Processing timelines for the new system have not yet been published.
Medical Device Registration Costs in Switzerland
Medical device registration costs in Switzerland vary depending on the device’s risk class, regulatory pathway, and the scope of conformity assessment activities. Manufacturers should account for both one-time registration expenses and ongoing compliance costs.
Key cost components include:
- Device classification and conformity assessment
- Notified body fees (where applicable)
- Technical documentation and clinical evaluation
- ISO 13485 certification and quality management system (QMS) implementation
- CH-REP services and regulatory consulting
- Translation, registration, and post-market surveillance costs
Manufacturers should develop a comprehensive regulatory budget that covers both initial market entry and long-term compliance obligations.
Import Requirements for Medical Devices in Switzerland
Any Switzerland-based person or entity placing a foreign-manufactured device on the Swiss market qualifies as an importer under the MedDO. Article 53 sets out the importer’s responsibilities. Importers must verify compliance before market placement.
Key obligations include:
- Verifying the CE marking and conformity assessment, where applicable
- Confirming the availability of the Declaration of Conformity
- Checking the device labeling, UDI, and CH-REP information
- Informing both the manufacturer and the CH-REP of any suspected non-compliance before distribution
Importers must also display their name, registered business address, and contact details on the device, packaging or an accompanying document. Importers must register with Swissmedic and obtain a CHRN. Distributors don’t carry this requirement. This difference between the two roles matters when setting up a Swiss supply chain.
Post-Market Surveillance Requirements in Switzerland
Manufacturers must maintain a Post-Market Surveillance (PMS) system throughout the device lifecycle in accordance with the MedDO and IvDO. Serious incidents occurring in Switzerland must be reported directly to Swissmedic within the applicable regulatory timelines. For manufacturers established outside Switzerland, the Swiss Authorized Representative (CH-REP) is responsible for submitting these reports.
Switzerland does not currently use EUDAMED for vigilance reporting. Until Swissdamed becomes fully operational, manufacturers must follow Swissmedic’s reporting procedures.
Manufacturers must also maintain ongoing PMS documentation, including PMS Reports, Periodic Safety Update Reports (PSURs), and Post-Market Clinical Follow-up (PMCF) activities, as applicable.
| Reporting Activity | Timeline |
| Serious public health threat | Within 2 days |
| Death or unanticipated serious deterioration | Within 10 days |
| Other serious incidents | Within 15 days |
| Field Safety Corrective Action (FSCA) |
Before or at the time the action is initiated
|
| Trending reporting |
When reporting thresholds are met
|
PSUR frequency:
- Class III and implantable devices: At least annually
- Class IIb devices: At least annually
Vigilance reporting in Switzerland is conducted directly through Swissmedic, as EUDAMED does not currently support Swiss reporting requirements.
Conclusion
Switzerland’s medical device regulations largely align with EU MDR and EU IVDR. But that alignment doesn’t cover everything. Manufacturers must still meet Swiss-specific requirements, including CH-REP appointment, CHRN registration, Swiss labeling and vigilance reporting.
Handling these obligations early helps manufacturers to move faster and with fewer regulatory delays along the way.
If you’re planning to place a medical device on the Swiss market and need guidance with registration, compliance, or market entry, reach out to info@artixio.com. Our medical device regulatory affairs experts can help you navigate the Swiss requirements efficiently and confidently.
FAQs
Q1. Is Switzerland part of the EU medical device system?
No. The EU-Swiss Mutual Recognition Agreement lapsed and Switzerland now operates its own Medical Device Regulatory Requirements in Switzerland under MedDO and IvDO . Both still closely mirror EU MDR and EU IVDR.
Q2. Do I need a CH-REP if I already have an EU Authorized Representative?
Yes. The two roles are legally separate. Foreign manufacturers without a registered place of business in Switzerland must appoint a CH-REP regardless of their EU representation arrangements.
Q3. Does CE marking alone allow market access in Switzerland?
Not by itself. A valid CE mark from a recognized notified body is necessary, but the Switzerland Medical Device Registration Process also requires CHRN registration, CH-REP appointment and compliant labeling before a device can legally be placed on the market.
Q4. What language must labeling and IFUs be in?
German, French and Italian, with limited exemptions for professional-use-only devices.
Q5. Who handles incident reporting for foreign manufacturers?
The CH-REP submits serious incident reports to Swissmedic on behalf of manufacturers without a Swiss establishment.
